| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/25/2004 | WO2004007722A3 Transgenic animal expressing alzheimer’s tau protein |
| 03/25/2004 | WO2003106640A3 Cell targeting methods and compositions |
| 03/25/2004 | WO2003102174A3 Modified phytases |
| 03/25/2004 | WO2003100001A3 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/25/2004 | WO2003098992A3 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003091401A3 Multi plasmid system for the production of influenza virus |
| 03/25/2004 | WO2003088996A3 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 03/25/2004 | WO2003087340A3 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 03/25/2004 | WO2003084468A3 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
| 03/25/2004 | WO2003083064A3 Chimeric pancreas |
| 03/25/2004 | WO2003082145A3 Fabrication of vascularized tissue using microfabricated two-dimensional molds |
| 03/25/2004 | WO2003081993A3 Transgenic aves producing human polyclonal antibodies |
| 03/25/2004 | WO2003076472A3 Neoplasm specific antibodies and uses thereof |
| 03/25/2004 | WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto |
| 03/25/2004 | WO2003070875B1 Container with at least one electrode |
| 03/25/2004 | WO2003064586A3 Method and device for cultivating cells in high densities and for obtaining products from said cells |
| 03/25/2004 | WO2003060061A9 Chamber with adjustable volume for cell culture and organ assist |
| 03/25/2004 | WO2003057823A3 Epitope synchronization in antigen presenting cells |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003045427A3 Pharmaceutical composition for inducing an immune response in a human or animal |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003035828A3 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003033659A3 Antisense modulation of matrix metalloproteinase 1 expression |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003023022A3 Method to induce the differentiation of endothelial cells to cardiomyocites |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2002101070A3 Alpha 2 integrin: modulators of lymphocyte activation |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002095497A3 Method of lift-off microstructuring deposition material on a substrate, substrates obtainable by the method, and use thereof |
| 03/25/2004 | WO2002092756A8 Insulin producing cells derived from human embryonic stem cells |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells |
| 03/25/2004 | WO2002051433A3 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | US20040060083 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
| 03/25/2004 | US20040060082 Generating soybean plants with single locus dominant alleles for propagating plants with enhanced oil production and improved agronomic characteristics |
| 03/25/2004 | US20040060080 Gibberellin 2-oxidase gene, functions and uses thereof |
| 03/25/2004 | US20040060079 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 03/25/2004 | US20040058887 Releasing drug, cosmetics to cells; flexible kinetics release patterns |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058445 Transgenic lymphocyte culture capable of inducing tumor destructive immunological response; immunotherapy |
| 03/25/2004 | US20040058444 Bioprosthetic heart valves |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058442 Oral progenitor cell culture for propagation and transplantion into oral cavity; restorative/regenerative dentistry |
| 03/25/2004 | US20040058441 Using bird stem cell to propagate transgenic tissues which generate therapeutic vaccine for treatment of cancer; immunotherapy |
| 03/25/2004 | US20040058440 Tissue growth method and apparatus |
| 03/25/2004 | US20040058439 High titer recombinant AAV production |
| 03/25/2004 | US20040058434 Bio-reactor for tissue cultivated in form of a thin layer and uses thereof |
| 03/25/2004 | US20040058427 Herbicide resistant plants |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058412 Cell populations which co-express CD49c and CD90 |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058397 Monoclonal antibody for identifying and recovering mesenchymal stem cells; hematopoietic stem cell proliferation, maturation and differentiation |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058392 Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058362 Polymerase chimeras |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058355 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of brain, breast disorders, colon, kidney, inflammatory, brain and urogenital disorders |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058344 Transgenic cells comprising precursor messenger RNA for diagnosis of infectious, cell proliferative, nervous system and metabolic disorders |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058324 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058316 Use of recombinant antigens to determine the immune status of an animal |
| 03/25/2004 | US20040058309 Blood composition for use in bioartificial liver for in vitro detoxification and treatment of hepatocyte disfunction |
| 03/25/2004 | US20040058010 Drugs, bio-affecting and body treating compositions |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057952 Where antibodies and antibody fragments recognize extracellular epitopes of plasma membrane proteins that are not released into the extracellular fluid; methods for detection, monitoring and treatment of cancer |
| 03/25/2004 | US20040057942 Used to reengineer damaged or diseased tissue, to augment existing tissue, to create new tissue, or to otherwise improve the condition of a patient who is suffering from disorder |
| 03/25/2004 | US20040057936 Tissue is soaked in a cold stabilizing solution; soaking in polyglycol, salt, hydrogen peroxide, and phosphate buffer; soaking in alcohol soaling in solution of an anti-inflammatory agent, an anti-thrombic agent, alcohol, and water |
| 03/25/2004 | US20040057933 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057932 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057931 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057930 Method for the development of an HIV vaccine |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | DE10111682B4 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use |
| 03/25/2004 | CA2538118A1 Sperm cell preservation and processing systems |
| 03/25/2004 | CA2499245A1 Method and apparatus for sorting particles |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2499215A1 A method of treating an autoimmune disease |
| 03/25/2004 | CA2499078A1 Regulating .beta.-catenin levels |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |